Click (CLIK) Stock Price, News & Analysis

Company Overview

Click Therapeutics, Inc. (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review. Several of its lead digital therapeutics have earned Breakthrough Device designation from the U.S. Food and Drug Administration and have pursued CE marking for commercialization in Europe. The company collaborates with pharmaceutical partners, academic institutions and healthcare providers to integrate its digital products into clinical pathways and to collect real-world evidence supporting safety and efficacy.

Headquartered in New York City, Click operates in the United States with strategic alliances in select international markets. Its leadership team draws on deep experience in digital health innovation, neuroscience research and pharmaceutical development. Click continues to invest in research and development, aiming to expand its pipeline into new therapeutic areas and to scale adoption of its digital therapeutics globally.

Key Stats

• Today's Range: $1.36 to $1.44
• 50-Day Range: $1.37 to $2.03
• 52-Week Range: $1.32 to $14.40
• Volume: 18,935 shs
• Average Volume: 369,804 shs
• Market Capitalization: $1.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Click Stock Analysis - MarketRank™

Click scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Click has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Click has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Click has a P/B Ratio of 0.09. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.17% of the float of Click has been sold short.

Short Interest Ratio / Days to Cover

Click has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Click has recently decreased by 94.86%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Click does not currently pay a dividend.

Dividend Growth

Click does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Click this week, compared to 2 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Click insiders have not sold or bought any company stock.

Percentage Held by Institutions

Click has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 8/04/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Industrials
• Industry: Professional Services
• Sub-Industry: Human Resource & Employment Services
• Current Symbol: NASDAQ:CLIK
• CIK: 2020027
• Web: N/A
• Phone: 852 3758 2780
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.26
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $10.71 million
• Price / Sales: 0.15
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.75 per share
• Price / Book: 0.09

Miscellaneous

• Outstanding Shares: 1,150,000
• Free Float: N/A
• Market Cap: $1.58 million
• Optionable: N/A
• Beta: 2.47